课题基金 / 基金详情

Experimental Animal Facility

Experimental Animal Facility
实验动物设施
批准号:
8038249
负责人:
KAM-MENG TCHOU-WONG
金额:
$7.02万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

KAM-MENG TCHOU-WONG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of the Experimental Animal and Exposure Core Facility is to provide a highly specialized shared resource to support the scientific needs of members of the NYU Cancer Institute for cancer-related animal research in carcinogenesis models and in carcinogen administration. The facility consists of two ntegrated units, the Animal Care and Exposure Unit and the Inhalation Exposure Unit, which provides specialized animal care, technical assistance for experiments with rodent species involving delivery of carcinogenic and toxic chemicals, infectious agents for challenge experiments, or intervention compounds for chemoprevention or chemotherapy via various routes of exposure including inhalation, systemic, dermal, and oral administration. In addition, several radiation equipments for skin irradiation of laboratory animals with electrons, UV and X-ray are also available. The Animal Care and Exposure Unit and the Inhalation Exposure Unit of the resource provide unique services that are not offered elsewhere at NYU School of Medicine; in fact, the Inhalation Exposure Unit is one of the largest academic facilities of its kind. We provide expertise in experimental design and conduct for cancer-related animal studies and necropsy services for animal experiments. Another unique service we provide is segregated housing and health monitoring of animals that do not yet have a proven virus antibody-free (VAF) status or that carry transplantable tumors that have not yet been MAP tested; work with these types of animals allows feasibility or pilot studies and small experiments with these animals. By providing comprehensive scientific consultation and collaboration on carcinogenesis animal models and carcinogen exposure, our primary goal is to facilitate and enhance scientific interaction and productivity among NYUCI investigators. This shared resource is available to all members of the NYU Cancer Institute and other members of the NYU community, but Cancer Institute members have priority over nonmembers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of cell-permeable antibodies for post-exposure treatment of ricin
Experimental Pathology
Development of cell-permeable antibodies for post-exposure treatment of ricin
Experimental Animal Facility
海外基金